CS-101 in Patients With β-thalassemia

Clinical trial NCT06328764 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06328764
Sponsor: CorrectSequence Therapeutics Co., Ltd
Status: ENROLLING_BY_INVITATION
Phase: Early Phase 1
Study type: INTERVENTIONAL

Beta-Thalassemia

Start date: 2024-03-19
Primary completion: 2026-07-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.